{"url_path":"/sec/bpth/8-k/2026-07-16/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000218-index.html","accession_number":"0001663577-26-000218","cik":"0001133818","ticker":"BPTH","issuer_name":"BIO-PATH HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1133818/0001663577-26-000218-index.html","primary_entity_key":"0001133818","primary_entity_name":"BIO-PATH HOLDINGS, INC."},"word_count":76,"has_tables":true,"body_markdown":"**Item 3.02 Unregistered Sales of Equity\nSecurities.**\n\n** **\n\nOn April 30, 2026, under our qualified Tier\n1 Regulation A offering, we sold 466,100 common shares to a third-party raising $13,983 in net proceeds. On May 13, 2026, under our qualified\nTier 1 Regulation A offering, we sold 489,200 common shares to a third-party raising $14,676 in net proceeds. We have the capability to\nraise an additional $571,341 under the qualified offering though there can be no assurances."}